Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-04965/USCOURTS-cand-4_04-cv-04965-2/pdf.json

Nature of Suit Code: 362
Nature of Suit: Medical Malpractice
Cause of Action: 28:1331 Fed. Question: Tort Action

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION OF PLAINTIFF & BOEHRINGER-INGELHEIM TO DISMISS CLAIMS WITH PREJUDICEDimmick v. NCIRE et al. C-04-04965 PJH

KATE WELLS, SB# 107051

2600 Fresno Street

Santa Cruz, California 95062

Telephone: (831) 479-4475

Facsimile: (831) 479-4476

Email: lioness@got.net

SALLY A. WILLIAMS, SB # 129181

Post Office Box 1478

Aptos, CA 95001-1478

Telephone: (831) 459-6096

Facsimile: (831) 688-1772

Email: sallyawilliams@sbeglobal.net 

Attorneys for Plaintiff, KEVIN DIMMICK

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

KEVIN DIMMICK, ) E-FILING CASE 

) 

Plaintiff, ) No. C 04-04965 PJH 

 vs. ) 

) STIPULATION OF THE 

 ) PLAINTIFF AND DEFENDANT 

NORTHERN CALIFORNIA INSTITUTE ) BOEHRINGER INGELHEIM )

 PHARMACEUTICALS INC. FOR

FOR RESEARCH & EDUCATION, ) DISMISSAL WITH PREJUDICE

BOEHRINGER-INGELHEIM ) OF THE CLAIMS AGAINST

PHARMACEUTICALS, INC., a Delaware ) IT; ORDER

Corporation doing business in California, ) 

UNIVERSITY OF CALIFORNIA/BOARD ) 

OF REGENTS OF THE STATE OF ) 

CALIFORNIA, ABBOTT ) 

LABORATORIES, INC., an Illinois ) 

Corporation doing business in California ) 

(Substituted in for DOE Number 1, and ) 

DOES 2 THROUGH 100, ) 

) 

Defendants. ) 

 )

The Plaintiff Kevin Dimmick (“Plaintiff”) and Defendant Boehringer Ingelheim

Pharmaceuticals, Inc., named as Boehringer-Ingelheim Pharmaceuticals, Inc. (“Boehringer

Ingelheim”), by and through their attorneys of record, hereby agree and stipulate to the dismissal with

prejudice of all claims, including the claims alleged in Plaintiff’s Fourth

Case 4:04-cv-04965-PJH Document 106 Filed 07/21/05 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION OF PLAINTIFF & BOEHRINGER-INGELHEIM TO DISMISS CLAIMS WITH PREJUDICEDimmick v. NCIRE et al. C-04-04965 PJH

Amended Complaint herein, against Defendant Boehringer Ingelheim. Each party hereby stipulates

and agrees to bear their own attorneys’ fees and costs incurred in this action.

SO STIPULATED:

LAW OFFICE OF KATE WELLS

Dated: July 20, 2005 /s/ 

KATE WELLS

Attorney for Plaintiff KEVIN DIMMICK

LAW OFFICES OF SALLY A. WILLIAMS

Dated: July 20, 2005 /s/ 

 SALLY A. WILLIAMS

 Attorney for Plaintiff KEVIN DIMMICK

 LUCE, FORWARD, HAMILTON & SCRIPPS, LLP 

 

Dated: July 20, 2005 /s/ 

EDWARD PATRICK SWAN, JR.

Attorneys for Defendant 

BOEHRINGER INGELHEIM

PHARMACEUTICALS, INC.

SO ORDERED BY STIPULATION

Any and all claims, including the claims alleged in Plaintiff’s Fourth Amended

Complaint herein, against Defendant Boehringer Ingelheim Pharmaceuticals, Inc., named as

Boehringer-Ingelheim Pharmaceuticals, Inc. (“Boehringer Ingelheim”), are hereby dismissed

with prejudice. Plaintiff and Defendant Boehringer Ingelheim are to bear their own attorneys’ 

fees and costs incurred in this action.

Dated: 

THE HONORABLE PHYLLIS J. HAMILTON

U.S. DISTRICT COURT JUDGE

7/21/05

Case 4:04-cv-04965-PJH Document 106 Filed 07/21/05 Page 2 of 2